Who are Irrigation with PVI's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Polihexanide 2%.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/irrigation-with-pvi.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Irrigation with PVI — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Irrigation with PVI (Irrigation with PVI) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiseptic/Antimicrobial agent. Area: Infection prevention / Surgical care.

marketed Antiseptic/Antimicrobial agent Infection prevention / Surgical care Small molecule Live · refreshed every 30 min

Target snapshot

Irrigation with PVI (Irrigation with PVI) — The University of Texas Health Science Center, Houston. Povidone-iodine (PVI) irrigation acts as a broad-spectrum antimicrobial agent that kills bacteria, fungi, and viruses through oxidative damage to microbial cell membranes and nucleic acids.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Irrigation with PVI TARGET	Irrigation with PVI	The University of Texas Health Science Center, Houston	marketed	Antiseptic/Antimicrobial agent
Polihexanide 2%	Polihexanide 2%	University of Sao Paulo	phase 3	Antiseptic/Antimicrobial agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiseptic/Antimicrobial agent class)

The University of Texas Health Science Center, Houston · 1 drug in this class
University of Sao Paulo · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Irrigation with PVI — Competitive Intelligence Brief. https://druglandscape.com/ci/irrigation-with-pvi. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing